Pancreatic endocrine tumors (PETs) have long fascinated clini-cians, because some can
release biologically active hormones that cause distinct syndromes and provide important …

Nonfunctional neuroendocrine tumors of the pancreas (NF-PNETs) are a heterogeneous
group of neoplasms. Although rare, the incidence of NF-PNETs is increasing significantly …

The aim of this study was to evaluate the diagnostic value of a new somatostatin analog,
68Ga-labeled 1, 4, 7, 10-tetraazacyclododecane-N, N′, N ″, N ″′-tetraacetic acid-d …

Neuroendocrine tumors can originate almost everywhere in the body and consist of a great
variety of subtypes. This paper focuses on molecular imaging methods using nuclear …

Abstract Neuroendocrine tumors (NETs)[carcinoids, pancreatic neuroendocrine tumors
(pNETs)] are becoming an increasing clinical problem because not only are they increasing …

Over the last decade somatostatin receptor scintigraphy using various derivatives of long-
acting somatostatin analogues has gained its place in the management of pancreatic islet …

Radiolabeled octreotide analogs (Oct) and metaiodobenzylguanidine (MIBG) offer 2
different approaches for imaging and targeting metastatic gastroenteropancreatic …

Incidentally detected, sporadic, nonfunctional pancreatic neuroendocrine tumors are
increasingly diagnosed on imaging studies performed for unrelated purposes. Although their …

Aim The presence of somatostatin receptors in neuroendocrine tumors allows visualization
with radiolabeled somatostatin analogs in vivo. The aim of this prospective study was to …

Neuroendocrine tumors (NET) are a heterogeneous group of tumors that arise from
neuroendocrine cells. These tumors may arise from various organs, including lung, thymus …